Covered recipient · General Payments record
LUIS TORREGROSA
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2023
$3,228.40
- Reported across 71 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $515.66 | 6 |
| Education | $178.98 | 2 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $178.98 | 2 |
| Acerta Pharma LLC | $134.13 | 1 |
| Amgen Inc. | $121.46 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $120.12 | 1 |
| ABBVIE INC. | $78.12 | 1 |
| Organon LLC | $61.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $78.12 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999280725 | CMS |
| Amgen Inc. | $56.20 | 11/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020004405 | CMS |
| Amgen Inc. | $65.26 | 11/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020004403 | CMS |
| AstraZeneca Pharmaceuticals LP | $134.13 | 11/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1061182133 | CMS |
| Janssen Biotech, Inc. | $98.99 | 06/01/2023 | Education | Undisputed | 01/23/2026 | 988417021 | CMS |
| Janssen Biotech, Inc. | $79.99 | 11/09/2023 | Education | Undisputed | 01/23/2026 | 988417011 | CMS |
| Novartis Pharmaceuticals Corporation | $120.12 | 11/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 993419437 | CMS |
| Organon LLC | $61.83 | 11/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046996739 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.